Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB

May 16, 2019

Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.

149 Ansichten
origenis gmbh

Am Klopferspitz 19a
82152 Martinsried


Tel: +49.89.7801676.0

Fax: +49.89.7801676.777

email: info(at)

Contact Us